Skip to main content

Table 2 Hypothesis testing for fixed efects model on cefmetazole parameters

From: Optimal dosage of cefmetazole for intraoperative antimicrobial prophylaxis in patients undergoing surgery for colorectal cancer

Parameter Fixed effects model OBJ - 2 l.l.d. p-value
CL θ1 491.305   
θ1 + θ2 × Ccr 476.461 −14.844 0.001
θ1 + θ2 × 1 / Scr 486.958 −4.347 N.S.
θ1 × θ2Gender (Gender: male = 1, female = 0) 486.934 −4.371 N.S.
θ1; Age 65, θ2; Age < 65 491.291 −0.014 N.S.
θ1; Alb 3.8, θ2; Alb < 3.8 491.305 0 N.S.
θ1 + θ2 × (1 + (4 - stage)) 490.054 −1.251 N.S.
θ1 × θ2Procedure 491.074 −0.231 N.S.
θ1 + θ2 × BW 489.316 −1.989 N.S.
Vd θ1 × θ2Gender (Gender : male = 1, female = 0) 491.295 0.010 N.S.
θ1; Age 65, θ4; Age < 65 490.189 1.116 N.S.
θ1 + θ2 × BW 473.811 17.494 0.001
  1. -2 l.l.d. : −2 log likelihood difference
  2. N.S. Not significant